InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Duarte Ira, 首席财务官. Insider active across 3 companies, notably Heron Therapeutics, INC.. Aggregated, 28 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €70k. Activity tracked since 22 June 2023. The latest transaction was disclosed on 30 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Duarte Ira
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
3,850 股@ US$0.500.0021% mcap2.3% 占其流量Common StockSEC:0001193125-26-329720:1
3,326 股@ US$0.500.0018% mcap2.0% 占其流量Common StockSEC:0001193125-26-329720:3
13,535 股Common StockSEC:0001193125-26-329720:0
11,694 股Common StockSEC:0001193125-26-329720:2
3,874 股Common StockSEC:0001193125-26-308887:0
1,101 股@ US$0.470.0006% mcap0.6% 占其流量Common StockSEC:0001193125-26-308887:1
12,500 股Common StockSEC:0001193125-26-273552:0
3,555 股Common StockSEC:0001193125-26-273552:1
3,874 股Common StockSEC:0001193125-26-165304:0
11,695 股Common StockSEC:0001193125-26-034492:0
3,875 股Common StockSEC:0001193125-26-016423:0
11,694 股Common StockSEC:0001193125-25-264039:0
3,874 股Common StockSEC:0001193125-25-244560:0
11,695 股Common StockSEC:0000950170-25-102158:0
3,874 股Common StockSEC:0000950170-25-097498:0
433,653 股0Common SharesSEC:0001415889-25-018193:0
12,500 股Common StockSEC:0000950170-25-087534:0
11,694 股Common StockSEC:0000950170-25-063063:0
3,875 股Common StockSEC:0000950170-25-056492:0
3,874 股Common StockSEC:0000950170-25-007557:0
71,704 股@ US$0.65100.0% 占其流量Common SharesSEC:0001415889-25-000381:0
3,874 股Common StockSEC:0000950170-24-115927:0
3,875 股Common StockSEC:0000950170-24-085089:0
163,334 股0Common SharesSEC:0001415889-24-017689:0
12,500 股Common StockSEC:0000950170-24-074168:0
28 条申报中的 25 条
About Duarte Ira
Duarte Ira is Chief Financial Officer. The record shows 24 filings in total, and across the recent filings available, the period runs from 2023-06-26 to 2026-07-20, with 69647 euros of buys and 0 euros of sells. The companies listed are HERON THERAPEUTICS, INC. /DE/, Heron Therapeutics, INC., and TerrAscend Corp.
